| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12029-009-9085-8 |
| P698 | PubMed publication ID | 19705300 |
| P2093 | author name string | Keith D Lindor | |
| Ghulam Abbas | |||
| P2860 | cites work | Worldwide trends in mortality from biliary tract malignancies | Q21093310 |
| Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival | Q24535538 | ||
| Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors | Q24535796 | ||
| Cholangiocarcinoma complicating primary sclerosing cholangitis | Q24540424 | ||
| Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients | Q24542152 | ||
| Surgery for cholangiocarcinoma: the role of liver transplantation | Q24647147 | ||
| Dose-additive carcinogenicity of a defined mixture of "dioxin-like compounds" | Q24811245 | ||
| Cancer statistics, 2005 | Q29617572 | ||
| Major liver resection for carcinoma in jaundiced patients without preoperative biliary drainage | Q33179996 | ||
| Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma | Q33336011 | ||
| Phase II trial of cisplatin, interferon alpha-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer. | Q33339781 | ||
| Optimization of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma | Q33343774 | ||
| Epirubicin, cisplatin, and protracted infusion of 5-FU (ECF) in advanced intrahepatic cholangiocarcinoma | Q33359823 | ||
| Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin | Q33503141 | ||
| Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas | Q33914989 | ||
| Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States | Q33949931 | ||
| Liver fluke-associated cholangiocarcinoma | Q33960569 | ||
| Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. | Q33961881 | ||
| Liver and biliary tract cancer among chemical workers | Q68871233 | ||
| Carcinoma of the bifurcation of the hepatic ducts | Q71024603 | ||
| Hepatolithiasis associated with cholangiocarcinoma | Q72063803 | ||
| EUS-guided fine-needle aspiration cytodiagnosis of hilar cholangiocarcinoma: a case series | Q73053153 | ||
| Analysis of microsatellite instability, K-ras gene mutation and p53 protein overexpression in intrahepatic cholangiocarcinoma | Q74297042 | ||
| Biliary tract carcinoma complicating primary sclerosing cholangitis: evaluation with CT, cholangiography, US, and MR imaging | Q74408975 | ||
| Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma | Q74558715 | ||
| Two consecutive phase II studies of 5-fluorouracil/leucovorin/mitomycin C and of gemcitabine in patients with advanced biliary cancer | Q77321354 | ||
| Utility of staging laparoscopy in subsets of peripancreatic and biliary malignancies | Q77376720 | ||
| A new mucin antibody/enzyme-linked lectin-sandwich assay of serum MUC5AC mucin for the diagnosis of cholangiocarcinoma | Q79772782 | ||
| Diagnostic role of biliary pancreatic elastase for cholangiocarcinoma in patients with cholestasis | Q80638690 | ||
| Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma | Q81148310 | ||
| The platelet-lymphocyte ratio improves the predictive value of serum CA19-9 levels in determining patient selection for staging laparoscopy in suspected periampullary cancer | Q81151072 | ||
| Serum cytokeratin 19 fragment (CYFRA21-1) as a prognostic factor in intrahepatic cholangiocarcinoma | Q81484743 | ||
| Changing international trends in mortality rates for liver, biliary and pancreatic tumours | Q33962674 | ||
| A conceptual proposal for staging ductal cholangiocarcinoma | Q33966175 | ||
| Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings | Q33967898 | ||
| The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis | Q33989725 | ||
| Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States | Q33996990 | ||
| Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study | Q34065939 | ||
| Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis | Q34409622 | ||
| Distinct evolution of the human carcinoma-associated transmembrane mucins, MUC1, MUC4 AND MUC16. | Q34497544 | ||
| Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study | Q34506385 | ||
| Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study | Q34543074 | ||
| Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma | Q34596626 | ||
| Enhanced detection of cholangiocarcinoma with serum trypsinogen-2 in patients with severe bile duct strictures | Q34653713 | ||
| Review of gemcitabine in biliary tract carcinoma | Q35063528 | ||
| Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma | Q35222052 | ||
| The epidemiology of cholangiocarcinoma | Q35802314 | ||
| The molecular pathogenesis of cholangiocarcinoma | Q35802318 | ||
| Diagnosis of pancreaticobiliary malignancy by detection of minichromosome maintenance protein 5 in bile aspirates. | Q36667380 | ||
| MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer. | Q36667483 | ||
| Single-agent gemcitabine for biliary tract cancers. Study outcomes and systematic review of the literature. | Q36688262 | ||
| Novel endoscopic approaches for assessing biliary tract diseases | Q37137378 | ||
| Diagnostic utility of interleukin-6 (IL-6) for primary bile duct cancer and changes in serum IL-6 levels following photodynamic therapy | Q38505216 | ||
| Randomised trial of endoscopic stenting versus surgical bypass in malignant low bileduct obstruction | Q39479518 | ||
| A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures | Q39678629 | ||
| Liver transplantation for cholangiocarcinoma: results in 207 patients | Q40762926 | ||
| External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma | Q41642762 | ||
| Phase II study of paclitaxel therapy for unresectable biliary tree carcinomas | Q42555316 | ||
| Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer | Q43601169 | ||
| FDG PET in the diagnosis of hilar cholangiocarcinoma | Q43801540 | ||
| Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy | Q44849411 | ||
| Comparison of 5-fluorouracil, doxorubicin and mitomycin C with 5-fluorouracil alone in the treatment of pancreatic-biliary carcinomas | Q44896529 | ||
| Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio. | Q45241867 | ||
| IgG4-associated cholangitis: a comparative histological and immunophenotypic study with primary sclerosing cholangitis on liver biopsy material | Q45346639 | ||
| Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study | Q47374399 | ||
| Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays | Q47960817 | ||
| Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis | Q48516720 | ||
| Phase II trial of intravenous flourouracil and subcutaneous interferon alfa-2b for biliary tract cancer | Q50163824 | ||
| Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis. | Q53524243 | ||
| Cholangiocarcinoma | Q57758190 | ||
| A Comparison of Routine Cytology and Fluorescence in situ Hybridization for the Detection of Malignant Bile Duct Strictures | Q59150858 | ||
| Pathological aspects of cholangiocarcinoma | Q67268511 | ||
| P433 | issue | 1-2 | |
| P921 | main subject | cholangiocarcinoma | Q124292 |
| ascending cholangitis | Q603644 | ||
| primary sclerosing cholangitis | Q1058608 | ||
| P304 | page(s) | 19-25 | |
| P577 | publication date | 2009-08-25 | |
| P1433 | published in | Journal of gastrointestinal cancer | Q27722079 |
| P1476 | title | Cholangiocarcinoma in primary sclerosing cholangitis | |
| P478 | volume | 40 |
| Q51769275 | Candidate genes involving in tumorigenesis of cholangiocarcinoma induced by Opisthorchis viverrini infection. |
| Q37812575 | Hilar cholangiocarcinoma: Pathology and tumor biology |
| Q38127390 | Imaging bile duct tumors: pathologic concepts, classification, and early tumor detection |
| Q64229475 | Meta-analysis of the diagnostic value of Wisteria floribunda agglutinin-sialylated mucin1 and the prognostic role of mucin1 in human cholangiocarcinoma |
| Q48093833 | The Diagnostic Roles of Cytokines in Hepatobiliary Cancers |
| Q35956062 | The Role of Biliary Carcinoembryonic Antigen-Related Cellular Adhesion Molecule 6 (CEACAM6) as a Biomarker in Cholangiocarcinoma |
Search more.